Should multifocality be an indication for prophylactic central neck dissection in papillary thyroid cancer?
Bilaterality
Multifocality
Papillary thyroid cancer
Journal
Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
01
03
2022
accepted:
23
02
2023
medline:
29
3
2023
pubmed:
6
3
2023
entrez:
5
3
2023
Statut:
ppublish
Résumé
Although multifocality is common in patients with papillary thyroid cancer, its effects on lymphatic metastasis and the necessity of central dissection in the presence of multifocality are still controversial. In our clinic, 258 patients who underwent thyroidectomy between 2015 and 2020 and were found to have papillary thyroid cancer in postoperative pathology reports were analyzed. The tumor characteristics contributing to central lymph node metastasis positivity were evaluated. Lymph node metastases were not significantly increased in the presence of multifocality. In cases with bilateral multifocal tumors, compared to cases with unilateral multifocal tumors, capsular invasion (p = 0.02), vascular invasion (p = 0.01) and cervical lymphatic metastasis (p = 0.004) were observed to increase. Bilateral multifocal tumors have more aggressive clinicopathological features than unilateral tumors. We found that the risk of central lymph node metastasis increased significantly in bilateral multifocal tumors in our study. Prophylactic central lymph node dissection may be considered in patients with no preoperative or intraoperative lymph node metastasis but thought to have a multifocal tumor.
Identifiants
pubmed: 36871277
doi: 10.1007/s13304-023-01479-7
pii: 10.1007/s13304-023-01479-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
701-706Informations de copyright
© 2023. Italian Society of Surgery (SIC).
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
doi: 10.3322/caac.21492
pubmed: 30207593
Markovina S, Grigsby PW, Schwarz JK et al (2014) Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence. Thyroid 24(7):1121–1126. https://doi.org/10.1089/thy.2013.0297
doi: 10.1089/thy.2013.0297
pubmed: 24731094
He Q, Zhuang D, Zheng L et al (2012) The surgical management of papillary thyroid microcarcinoma: a 162-month single-center experience of 273 cases. Am Surg 78(11):1215–1218
doi: 10.1177/000313481207801127
pubmed: 23089437
Lee YS, Lim YS, Lee JC, Wang SG, Kim IJ, Lee BJ (2010) Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. World J Surg 34:2558–2563
doi: 10.1007/s00268-010-0749-0
pubmed: 20703463
Degroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–24
doi: 10.1210/jcem-71-2-414
pubmed: 2380337
Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH (2013) Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg 37(2):376–384. https://doi.org/10.1007/s00268-012-1835-2
doi: 10.1007/s00268-012-1835-2
pubmed: 23135422
Lin JD, Chao TC, Hsueh C, Kuo SF (2009) High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol 16(9):2609–2616. https://doi.org/10.1245/s10434-009-0565-7
doi: 10.1245/s10434-009-0565-7
pubmed: 19533244
Pitt SC, Sippel RS, Chen H (2009) Contralateral papillary thyroid cancer: does size matter? Am J Surg 197(3):342–347. https://doi.org/10.1016/j.amjsurg.2008.09.011
doi: 10.1016/j.amjsurg.2008.09.011
pubmed: 19245912
pmcid: 2679519
Koo BS, Lim HS, Lim YC, Yoon YH, Kim YM, Park YH et al (2010) Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma. Ann Surg Oncol 17:1101–1105
doi: 10.1245/s10434-009-0906-6
pubmed: 20066517
Elisei R, Molinaro E, Agate L et al (2010) Are the clinical and pathological features of differentiated thyroid carcinoma truly changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 95(4):1516–1527. https://doi.org/10.1210/jc.2009-1536
doi: 10.1210/jc.2009-1536
pubmed: 20156922
Wang W, Wang H, Teng X et al (2010) Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. Hum Pathol 41(9):1299–1309. https://doi.org/10.1016/j.humpath.2010.02.008
doi: 10.1016/j.humpath.2010.02.008
pubmed: 20471663
Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A (2011) Aggressive variants of papillary thyroid carcinoma. Head Neck 33(7):1052–1059. https://doi.org/10.1002/hed.21494
doi: 10.1002/hed.21494
pubmed: 20824810
Ito Y, Miyauchi A, Kihara M, Kobayashi K, Miya A (2014) Prognostic values of clinical lymph node metastasis and macroscopic extrathyroid extension in papillary thyroid carcinoma. Endocr J 61(8):745–750. https://doi.org/10.1507/endocrj.ej14-0138
doi: 10.1507/endocrj.ej14-0138
pubmed: 24739332
Pelizzo MR, MeranteBoschin I, Toniato A et al (2008) Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma. Minerva Endocrinol 33(4):359–379
pubmed: 18923371
Wang W, Zhao W, Wang H et al (2012) Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma. Ann Surg Oncol 19(1):31–36. https://doi.org/10.1245/s10434-011-2096-2
doi: 10.1245/s10434-011-2096-2
pubmed: 22033631
Karatzas T, Vasileiadis I, Charitoudis G, Karakostas E, Tseleni-Balafouta S, Kouraklis G (2013) Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy. Hormones (Athens) 12(4):529–536
doi: 10.14310/horm.2002.1441
pubmed: 24457401
Suh YJ, Kwon H, Kim SJ et al (2015) Factors affecting the locoregional recurrence of conventional papillary thyroid carcinoma after surgery: a retrospective analysis of 3381 patients. Ann Surg Oncol 22(11):3543–3549. https://doi.org/10.1245/s10434-015-4448-9
doi: 10.1245/s10434-015-4448-9
pubmed: 25743326
Mao J, Zhang Q, Zhang H, Zheng K, Wang R, Wang G (2020) Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 11:265. https://doi.org/10.3389/fendo.2020.00265
doi: 10.3389/fendo.2020.00265
pubmed: 32477264
Qu N, Zhang L, Ji QH, Zhu YX, Wang ZY, Shen Q et al (2014) Number of tumor foci predicts prognosis in papillary thyroid cancer. BMC Cancer 14:914
doi: 10.1186/1471-2407-14-914
pubmed: 25471041
pmcid: 4289292
Qu N, Zhang L, Wu WL, Ji QH, Lu ZW, Zhu YX et al (2016) Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer. Tumor Biol 37:8783–8789
doi: 10.1007/s13277-015-4533-5
Giordano D, Valcavi R, Thompson GB et al (2012) Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid 22(9):911–917. https://doi.org/10.1089/thy.2012.0011
doi: 10.1089/thy.2012.0011
pubmed: 22827494